Patents by Inventor John R. Shainoff

John R. Shainoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glyoxal agarose and zonal immobilization of proteins therewith
    Patent number: 4312727
    Abstract: A new composition of matter is provided having novel, valuable attributes in the zonal immobilization of proteins of biochemical origin which expands man's capacity to separate, isolate, detect, and sequentially sorb and desorb, concentrate, and quantify and qualify picomole size samples or specimens of complex proteins of biochemical origin into fundamentally interesting fractions for studies to expand the understanding of, illustratively, the complex proteins in lesions of atherosclerosis, antigens, antibodies, enzyme immobilization in studies of enzymatic actions in body tissues and functions, immunoglobulins, genetic aberrations, molecular size separations of complex proteins, and extends the sensitivity of detection of such isolates beyond that achievable by prior art radio immunoassay techniques.
    Type: Grant
    Filed: September 30, 1980
    Date of Patent: January 26, 1982
    Assignee: The Cleveland Clinic Foundation
    Inventor: John R. Shainoff
  • Glyoxal agarose
    Patent number: 4275196
    Abstract: A new composition of matter is provided having novel, valuable attributes in the zonal immobilization of proteins of biochemical origin which expands man's capacity to separate, isolate, detect, and sequentially sorb and desorb, concentrate, and quantify and qualify picomole size samples or specimens of complex proteins of biochemical origin into fundamentally interesting fractions for studies to expand the understanding of, illustratively, the complex proteins in lesions of atherosclerosis, antigens, antibodies, enzyme immobilization in studies of enzymatic actions in body tissues and functions, immunoglobulins, genetic aberrations, molecular size separations of complex proteins, and extends the sensitivity of detection of such isolates beyond that achievable by prior art radio immunoassay techniques.
    Type: Grant
    Filed: March 23, 1979
    Date of Patent: June 23, 1981
    Assignee: The Cleveland Clinic Foundation
    Inventor: John R. Shainoff